了解胆道癌症中同源重组修复缺陷:临床含义和与敏感性的相关性

I-A Mavroeidi1, J Burghofer2, S Kalbourtzis3

  • 1Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen; Division of Solid Tumor Translational Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.

ESMO open
|July 17, 2024
PubMed
概括

同类重组修复 (HRR) 基因的基因变异在27.5%的胆道癌症患者中被发现. 患有HRR基因突变的患者在一线化疗时显示出潜在的整体生存优势.